Literature DB >> 18077373

Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory.

Ying Zhang1, Alessandro Bertolino, Leonardo Fazio, Giuseppe Blasi, Antonio Rampino, Raffaella Romano, Mei-Ling T Lee, Tao Xiao, Audrey Papp, Danxin Wang, Wolfgang Sadée.   

Abstract

Subcortical dopamine D2 receptor (DRD2) signaling is implicated in cognitive processes and brain disorders, but the effect of DRD2 variants remains ambiguous. We measured allelic mRNA expression in postmortem human striatum and prefrontal cortex and then performed single nucleotide polymorphism (SNP) scans of the DRD2 locus. A previously uncharacterized promoter SNP (rs12364283) located in a conserved suppressor region was associated with enhanced DRD2 expression, whereas previously studied DRD2 variants failed to affect expression. Moreover, two frequent intronic SNPs (rs2283265 and rs1076560) decreased expression of DRD2 short splice variant (expressed mainly presynaptically) relative to DRD2 long (postsynaptic), a finding reproduced in vitro by using minigene constructs. Being in strong linkage disequilibrium with each other, both intronic SNPs (but not rs12364283) were also associated with greater activity of striatum and prefrontal cortex measured with fMRI during working memory and with reduced performance in working memory and attentional control tasks in healthy humans. Our results identify regulatory DRD2 polymorphisms that modify mRNA expression and splicing and working memory pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18077373      PMCID: PMC2154469          DOI: 10.1073/pnas.0707106104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Inhibitory control of the GABAergic transmission in the rat neostriatum by D2 dopamine receptors.

Authors:  A Delgado; A Sierra; E Querejeta; R F Valdiosera; J Aceves
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  Distinct functions of the two isoforms of dopamine D2 receptors.

Authors:  A Usiello; J H Baik; F Rougé-Pont; R Picetti; A Dierich; M LeMeur; P V Piazza; E Borrelli
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

3.  Allelic variation in human gene expression.

Authors:  Hai Yan; Weishi Yuan; Victor E Velculescu; Bert Vogelstein; Kenneth W Kinzler
Journal:  Science       Date:  2002-08-16       Impact factor: 47.728

4.  Single nucleotide polymorphism genotyping using allele-specific PCR and fluorescence melting curves.

Authors:  Audrey C Papp; Julia K Pinsonneault; Glen Cooke; Wolfgang Sadée
Journal:  Biotechniques       Date:  2003-05       Impact factor: 1.993

5.  Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice.

Authors:  C Cepeda; R S Hurst; K L Altemus; J Flores-Hernández; C R Calvert; E S Jokel; D K Grandy; M J Low; M Rubinstein; M A Ariano; M S Levine
Journal:  J Neurophysiol       Date:  2001-02       Impact factor: 2.714

6.  Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors.

Authors:  Diego Centonze; Barbara Picconi; Christelle Baunez; Emiliana Borrelli; Antonio Pisani; Giorgio Bernardi; Paolo Calabresi
Journal:  Neuropsychopharmacology       Date:  2002-02       Impact factor: 7.853

7.  Functional variant in the DRD2 receptor promoter region and subtypes of alcoholism.

Authors:  A Parsian; C R Cloninger; Z H Zhang
Journal:  Am J Med Genet       Date:  2000-06-12

8.  Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor.

Authors:  Jubao Duan; Mark S Wainwright; Josep M Comeron; Naruya Saitou; Alan R Sanders; Joel Gelernter; Pablo V Gejman
Journal:  Hum Mol Genet       Date:  2003-02-01       Impact factor: 6.150

9.  Ethanol consumption and DRD2 gene TaqI a polymorphism among socially drinking males.

Authors:  Tero Hallikainen; J Hietala; J Kauhanen; T Pohjalainen; E Syvälahti; J T Salonen; J Tiihonen
Journal:  Am J Med Genet A       Date:  2003-06-01       Impact factor: 2.802

10.  Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning.

Authors:  Christoph Kellendonk; Eleanor H Simpson; H Jonathan Polan; Gaël Malleret; Svetlana Vronskaya; Vanessa Winiger; Holly Moore; Eric R Kandel
Journal:  Neuron       Date:  2006-02-16       Impact factor: 17.173

View more
  189 in total

Review 1.  Novel dopamine D2 receptor signaling through proteins interacting with the third cytoplasmic loop.

Authors:  Kohji Fukunaga; Norifumi Shioda
Journal:  Mol Neurobiol       Date:  2011-12-20       Impact factor: 5.590

2.  What is a functional genetic polymorphism? Defining classes of functionality.

Authors:  Paul R Albert
Journal:  J Psychiatry Neurosci       Date:  2011-11       Impact factor: 6.186

Review 3.  mRNA transcript diversity creates new opportunities for pharmacological intervention.

Authors:  Elizabeth S Barrie; Ryan M Smith; Jonathan C Sanford; Wolfgang Sadee
Journal:  Mol Pharmacol       Date:  2012-02-07       Impact factor: 4.436

4.  An association study on the polymorphisms of dopaminergic genes with working memory in a healthy Chinese Han population.

Authors:  Pingyuan Gong; Hang Zhang; Wanyu Chi; Wanhua Ge; Kejin Zhang; Anyun Zheng; Xiaocai Gao; Fuchang Zhang
Journal:  Cell Mol Neurobiol       Date:  2012-02-24       Impact factor: 5.046

Review 5.  Neuropsychopharmacology and neurogenetic aspects of executive functioning: should reward gene polymorphisms constitute a diagnostic tool to identify individuals at risk for impaired judgment?

Authors:  Abdalla Bowirrat; Thomas J H Chen; Marlene Oscar-Berman; Margaret Madigan; Amanda Lh Chen; John A Bailey; Eric R Braverman; Mallory Kerner; John Giordano; Siobhan Morse; B William Downs; Roger L Waite; Frank Fornari; Zaher Armaly; Kenneth Blum
Journal:  Mol Neurobiol       Date:  2012-02-28       Impact factor: 5.590

6.  Striatal dopamine D₂/D₃ receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans.

Authors:  Dara G Ghahremani; Buyean Lee; Chelsea L Robertson; Golnaz Tabibnia; Andrew T Morgan; Natalie De Shetler; Amira K Brown; John R Monterosso; Adam R Aron; Mark A Mandelkern; Russell A Poldrack; Edythe D London
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

7.  PharmGKB summary: dopamine receptor D2.

Authors:  Huaiyu Mi; Paul D Thomas; Huijun Z Ring; Ruhong Jiang; Katrin Sangkuhl; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-06       Impact factor: 2.089

8.  Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain.

Authors:  S S Kaalund; E N Newburn; T Ye; R Tao; C Li; A Deep-Soboslay; M M Herman; T M Hyde; D R Weinberger; B K Lipska; J E Kleinman
Journal:  Mol Psychiatry       Date:  2013-12-10       Impact factor: 15.992

9.  Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans.

Authors:  Alessandro Bertolino; Leonardo Fazio; Annabella Di Giorgio; Giuseppe Blasi; Raffaella Romano; Paolo Taurisano; Grazia Caforio; Lorenzo Sinibaldi; Gianluca Ursini; Teresa Popolizio; Emanuele Tirotta; Audrey Papp; Bruno Dallapiccola; Emiliana Borrelli; Wolfgang Sadee
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

10.  A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study.

Authors:  C J Spellicy; M J Harding; S C Hamon; J J Mahoney; J A Reyes; T R Kosten; T F Newton; R De La Garza; D A Nielsen
Journal:  Genes Brain Behav       Date:  2014-03-17       Impact factor: 3.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.